Menu
Explore
Activity
Issues
AI suggestions
Help center
Help center
Writing guide
Editor guide
Creating topics
Magic citations

Activity

Jonathan KrollJonathan Kroll was edited byJay KJay K
September 30, 2020 5:27 am
Topic thumbnail

Jonathan Kroll

Founder of RepresentYou

Venture Capitalist and Entrepreneur

Infobox
Current Employer
Spero Ventures
Founder of
Target Test Prep
Investment fund type
Venture capital fund
Investor
Spero Ventures
Occupation
Venture capital
Categories  (+4 topics)
Danimer ScientificDanimer Scientific was edited byNeelam JhaveriNeelam Jhaveri
September 30, 2020 4:34 am
Topic thumbnail

Danimer Scientific

Biorefinery company

Infobox
Stephen CroskreyStephen Croskrey was edited byNeelam JhaveriNeelam Jhaveri
September 30, 2020 4:32 am
Topic thumbnail

Stephen Croskrey

Infobox
Tapan SinghelTapan Singhel was edited byNeelam JhaveriNeelam Jhaveri
September 30, 2020 4:19 am
Topic thumbnail

Tapan Singhel

Infobox
Is a
Person
Al WalkerAl Walker was edited byAime Anne NisayAime Anne Nisay
September 30, 2020 3:06 am
Topic thumbnail

Al Walker

CEO

Documentaries, videos and podcasts  (+1 rows) (+5 cells) (+204 characters)

Title
Date
Link

Former Anadarko Petroleum CEO Al Walker Joins ConocoPhillips Board

March 6, 2020

Melo7 Tech PartnersMelo7 Tech Partners was edited byErin ScherfnerErin Scherfner
September 29, 2020 11:43 pm
Article  (+7 characters)

Melo7 was founded out of shared interest between Anthony and Goldfarb after the pair connected socially. Anthony's interest was piqued when the New York Knicks, his former NBA team, began using the Catapult wearable to track data analytics on player performance.

Timeline  (+1 events) (+71 characters)

2020

Melo7 Tech Partners was founded by Carmelo Anthony and Stuart Goldfarb.

Melo7 Tech PartnersMelo7 Tech Partners was edited byErin ScherfnerErin Scherfner
September 29, 2020 11:40 pm
Article  (+668 characters)

Melo7 Tech Partners is a venture capital firm founded by Stuart Goldfarb and NBA All-Star Carmelo Anthony and is located in New York, New York.

Melo7 was founded out of shared interest between Anthony and Goldfarb after the pair connected socially. Anthony's interest was piqued when the New York Knicks, his NBA team, began using the Catapult wearable to track data analytics on player performance.

...

The company primarily invests in early-stage digital media, consumer internet, and technology ventures. Menlo7 has made over 30 investments, 12 diversity investments, and has made 15 exits. It has invested in companies like Lyft, SeatGeek, Mercury, Bonobos, and more.

Infobox
Full address
New York, NY, 10017 United States
Number of Employees (ranges)
1–4
Ryan PawellRyan Pawell was edited byErin ScherfnerErin Scherfner
September 29, 2020 11:02 pm
Topic thumbnail

Ryan Pawell

Founder and CEO of indeeIndee labsLabs

Article  (+510 characters)

Ryan Pawell is the Founder and CEO of Indee Labs, a biotech company located in Berkley, California.

...

Pawell received a Bachelor's of Science Degree, Mechanical Engineering from UC Santa Barbara. While in college, Pawell had an internship at a medical device company started by three UCSB students. Although his internship was intended to last one summer, Pawell stayed with the company for 18 months. He developed an interest in stem cell regenerative medicine that led to his eventual founding of Indee Labs.

Sumon SadhuSumon Sadhu was edited byErin ScherfnerErin Scherfner
September 29, 2020 10:13 pm
Topic thumbnail

Sumon Sadhu

Founder of Snaptalent

Founder of Snaptalent and Chief Revenue Officer at Aesthetic.

Article  (+516 characters)

Sumon Sadhu is the founder of Snaptalent, a job advertisement network that closed in 2009. Sadhu now serves as the Chief Revenue Officer of Aesthetic (formerly Plato Design), a graphic design company.

...

Sadhu is a global angel investor participating in 4 exits and has invested in over 35 companies, including Benchling, Xendit, Mobius Motors, and Framed Data. He has invested money alongside several venture capital firms, including, but not limited to, Andreessen Horowitz, Benchmark Capital, and Sequoia Capital.

Chris LyonsChris Lyons was edited byErin ScherfnerErin Scherfner
September 29, 2020 9:50 pm
Article  (+374/-376 characters)

In 2012, Lyons moved to Silicon Valley to participate in the NewME Accelerator, an accelerator for start-ups led by minority peoples, but in 2013 he accepted a position alongside Ben Horowitz, co-founder of a16z, as the Chief of Staff. After five years serving as Chief of Staff, Lyons developed and became head of the Cultural Leadership Fund (CLF) at a16z, a $16.5 million

In 2012, Lyons moved to Silicon Valley to participate in the NewME Accelerator, an accelerator for start-ups led by minority peoples, but in 2013 he accepted a position alongside Ben Horowitz, co-founder of a16z, as the Chief of Staff. After five years serving as Chief of Staff, Lyons developed and became head of the Cultural Leadership Fund (CLF) at a16z, a $16.5 million fund. The CLF is a limited partnership between Andreesen Horowitz and influential global cultural leaders like Shonda Rhimes, Chance the Rapper, Quincy Jones, Will Smith, and Jada Pinkett-Smith. The fund is aimed to bring more cultural diversity into the tech industry. The fund has invested in startups such as Wonderschool, Overtime, and Propel.

Chris LyonsChris Lyons was edited byErin ScherfnerErin Scherfner
September 29, 2020 9:48 pm
Further reading  (+3 rows) (+15 cells) (+700 characters)

Title
Author
Link
Type
Date

A VC Fund Backed By Kevin Durant And Diddy Will Donate Its Profits To 11 Charities Improving Diversity In Tech

Biz Carson

Web

October 11, 2019

How this VC is helping black cultural power brokers like Shonda Rhimes and Chance the Rapper invest in tech

J.J. McCorvey

Web

May 22, 2019

Rasa raises $26M led by A16Z for its open source conversational AI platform

Ingrid Lunden

Web

June 23, 2020

Chris LyonsChris Lyons was edited byErin ScherfnerErin Scherfner
September 29, 2020 9:44 pm
Topic thumbnail

Chris Lyons

Managing Partner and Head of Cultural Leadership Fund at a16z.

Article  (+1572 characters)

Chris Lyons is a Managing Partner and the Head of the Cultural Leadership Fund at Andreesen Horowitz (a16z).

Education

Lyons attended Georgia State University, where he received an Associate's Degree in Business Management. Additionally, Lyons went to Full Sail University, where he received another two degrees, an Associate's of Science Degree, Recording Arts, and a Bachelor's of Science Degree, Entertainment Business.

Career

Lyons began his professional life in the music industry, first working as an event coordinator. In 2009 he took a job as a sound engineer for Jermaine Dupri, a Grammy-Award winning music producer based in Atlanta, Georgia. By 2010 Lyons had developed a restaurant application called PictureMenu, a digital menu that allowed restaurant patrons to not only view their meal before ordering but also rate the dish afterward.

In 2012, Lyons moved to Silicon Valley to participate in the NewME Accelerator, an accelerator for start-ups led by minority peoples, but in 2013 he accepted a position alongside Ben Horowitz, co-founder of a16z, as the Chief of Staff. After five years serving as Chief of Staff, Lyons developed and became head of the Cultural Leadership Fund (CLF) at a16z, a $16.5 million fund. The CLF is a limited partnership between Andreesen Horowitz and influential global cultural leaders like Shonda Rhimes, Chance the Rapper, Quincy Jones, Will Smith, and Jada Pinkett-Smith. The fund is aimed to bring more cultural diversity into the tech industry. The fund has invested in startups such as Wonderschool, Overtime, and Propel.

Infobox
Citizenship
United States
Current Employer
Andreessen Horowitz (a16z)
Education
Georgia State University
Founder of
PictureMenu
Known for
a16z Cultural Leadership Fund
Location
San Francisco
Birthplace
Atlanta
Better Tomorrow VenturesBetter Tomorrow Ventures was edited byErin ScherfnerErin Scherfner
September 29, 2020 8:45 pm
Article  (+516/-19 characters)

Better Tomorrow Ventures is a venture capital firm founded by Jake Gibson and Sheel Mohnot in January 2020. Better Tomorrow is located in San Francisco, California, and invests in the financial technology (FinTech) industry around the world.

Portfolio Companies

Gibson and Mohnot previously built the 500 FinTech accelerator, and Gibson is a co-founder of NerdWallet.

Together Gibson and Mohnot have invested in Albert, ChipperCash, Ethic, Drip Capital, Ethos Insurance, Hippo, Kin, and more. BTV is a $75 million fund investing in pre-seed and seed-stage FinTech and Software-as-a-Service (SaaS) funding internationally. BTV also consults with companies on mentorship in hiring, distribution, building company cultures, and forming partnerships between companies.

Invested in

Pizza Hut PetePizza Hut Pete was edited byCarla FaragunaCarla Faraguna
"removed copy/pasted content"
September 29, 2020 8:31 pm
Topic thumbnail

Pizza Hut Pete

The man with the floating hat is none other than Pizza Hut Pete . As far as I can tell, he started making pies for the pizza giant around 1...

Pizza Hut logo

Article  (-730 characters)

Pete helped his company's founders, Dan and Frank Carney, to build Pizza Hut into the largest restaurant chain in the world by 1971. He doesn't show up in the advertising anymore -- real-life celebrity endorsements have taken over the spotlight -- but Pete is still in the kitchen . . . and still smiling.

[While he was named Pete, I've also seen him referred to on Pizza Hut paper items simply as "Pizza Man".]

Two Pizza Hut Petes stood watch on the sign on our old Pizza Hut. The store was in a strip mall and the sign was to resemble the red roof with the name Pizza Hut in the middle. The two Pete's flanked the name. In the early eighties, the store moved to a new traditional red roof building, but Pete did not make the move.

Parse (company)Parse (company) was edited byErin ScherfnerErin Scherfner
September 29, 2020 8:23 pm
Infobox
Business model
Subscription
Competitors
Firebase
Timeline  (+4 events) (+343 characters)

January 31, 2017

Facebook's Parse developer platform is shutting down today

January 28, 2016

Facebook announces its closing the Parse developer platform.

April 25, 2013

Facebook buys Parse to offer mobile development tools.

Parse has agreed to be acquired by Facebook.

2011

Parse is founded by Tikhon Bernstam, James Yu, Ilya Sukhar, and Kevin Lacker as a part of Y Combinator's S11 Accelerator Batch.

NovartisNovartis was edited byAleksander HolmAleksander Holm
September 29, 2020 8:16 pm
Timeline  (+5 events) (+714 characters)

April 20, 2020

Novartis acquires Amblyotech, a startup that combines 3D glasses and video game software to treat amblyopia, more commonly known as "lazy eye".

November 24, 2019

Novartis entered into an agreement and plan of merger with The Medicines Company to acquire the US-based biopharmaceutical company for USD 85.00 per share in cash, valuing the company at approximately USD 9.7 billion on a fully diluted equity basis.

May 9, 2019

Novartis acquires Xiidra, expanding front-of-eye portfolio.

April 9, 2018

Novartis acquires AveXis, a gene therapy company, for $8.7 billion.

December 20, 2016

Swiss drug maker Novartis AG reached a definitive agreement to acquire Fort Worth, Texas-based Encore Vision, which is focused on developing a novel treatment in presbyopia, or far-sightedness.

Parse (company)Parse (company) was edited byErin ScherfnerErin Scherfner
September 29, 2020 8:13 pm
Topic thumbnail

Parse (company)

Parse is a company providing cloud-based software developer kits for building applications for desktop, mobile, and embedded devices. It participated in the S11 cohort of Y Combinator.

Article  (+1113 characters)

Founded by Tikhon Bernstam, James Yu, Ilya Sukhar, and Kevin Lacker, Parse is a cloud-based software developer providing kits for building desktop, mobile, and embedded device applications.

Parse was part of the Y Combinator S11 Batch, founded by participants of the 2011 Y Combinator Program, but was acquired by Facebook in 2013 for $85 million. Before Facebook acquired Parse, the platform was used by 20,000 mobile developers and saw a 40% customer increase monthly. By 2014, after the acquisition, it was reported the platform was hosting over 500,000 applications.

...

In January of 2016, Facebook announced it would be closing the Parse Hosting Service. However, the Parse code was open-sourced by Facebook, to allow the migration of apps to self-host. Parse provided a server, called MongoDB, allowing developers to migrate to a new self-hosted server while continuing to have access to the Parse dashboard. However, several vendors are capable of hosting Parse applications, allowing developers to move their applications to avoid self-hosting. On January 30th, 2018, Parse discontinued its hosting services.

Infobox
B2X
B2B
Company status
Closed
Email address
community@parse.com
Full address
Eight California Street, Suite 200, San Francisco, CA, 94111 United States
Number of Employees (ranges)
50–99
Parent organization
Facebook
NovartisNovartis was edited byAleksander HolmAleksander Holm
September 29, 2020 8:04 pm
Article  (+4824/-755 characters)

Novartis products include oncology medicines, generic and biosimilar medicines and eye carcare devices. The Innovative Medicine segment of the company is divided into Novartis Oncology and Novartis Pharmaceuticals. Novartis Pharmaceuticals consists of global business franchises in ophthalmology, neuroscience, immunology and dermatology, respiratory, cardio-metabolic and established medicines.

Divisions

Novartis Oncology

Novartis Oncology is focused on the development and manufacturing of medicines directed towards improving and extending people's lives.

Sandoz

...

Alcon

...

Novartis Gene Therapies

Previously known as AveXis, Novartis Gene Therapies works to develop and commercialize gene therapies. They have a specific focus on neurological genetic diseases. Their initial gene therapy is for spinal muscular atrophy and has been approved in the United States, Japan, the European Union, and Brazil.

Novartis Institutes for BioMedical Research (NIBR)

Part of their research and development program, the Novartis Institutes for BioMedical Research (NIBR) is working on developing informatics tools for drug discovery with a focus on open-sourced software.

Habitat

Habitat is a software developed to be a self-contained object storage management system. Based on Amazon Web Services, Novartis says Habitat is capable of virtually unlimited storage and can be used as a local repository for a single application or shared and used with many clients.

Yet Another Data Abstraction (YADA)

Novartis says Yet Another Data Abstraction (YADA) is a data aggregation tool capable of accessing data sets at any data source in any format and from any environment with a single URL and a single configuration. YADA is intended to be a lightweight framework for data retrieval, searching, storage, and manipulation.

OntoBrowser

OntoBrowser is a web-based application for managing ontologies. Developed by Novartis, they say the tool is intended to provide an online collaborative solution for curators to map code list terms to preferred ontology terms. OntoBrowser also offers visualization of ontologies in hierarchical or graph format, advanced search capabilities, and web service access to data.

Railroadtracks

Railroadtracks is a Python package Novartis says is intended to handle connected computation steps for DNA and RNA sequencing.

Yet Another Pipeline (YAP)

Yet Another Pipeline (YAP) is an extensible parallel framework developed by Novartis and written in Python using OpenMPI libraries. The software is intended to help researchers build high throughput data pipelines without knowledge of parallel programming.

RDKit

Developed by Novartis, the RDKit is a collection of cheminformatics and machine-learning softwre written in C++ and Python. The distribution includes a PostgreSQL-based cartridge allowing molecules to be stored in a relational database and allowing users to retrieve information via substructure and similarity searches.

GridVar

GridVar is a JQuery plugin that visualized multi-dimensional datasets as layers organized in a row-column format. Novartis says the software is intended to allow users to visualize data as a background color and enables characteristics of a dataset to be layered on top of each other.

Nerve Live

Developed by Novartis to use big data and data analytics, Nerve Live is an advanced analytics platform is intended to be used as part of a drug discovery program. Novartis sees the platform as enabling machine learning and cognitive computing systems to extract information which traditional data analysts and users might miss.

...

Novartis, previously called Ciba-Geigy, was one of the few pharmaceutical companies involved in tyrosine kinase inhibitor research when it began a collaboration with oncologist Brian Druker which resulted in discovery of the kinase inhibitor drug Gleevec (also known as Glivec or imatinib). Gleevec was FDA approved in 2001 to treat patients with chronic myelogenous leukemia (CML). Kinases perform phosphorylation, a mechanism that controls the activity of proteins in the cell. CML patients have a mutation causing their tyrosine kinase to be overactive, which signals cell to proliferate at a high rate, resulting in accumulation of immature white blood cells. Based on revenue, Gleevec was one of Novartis’s top ten pharmaceutical products in 2017.

The Nerve Live was developed by first building a data lake. This was followed by developing an analytics engine to process the data and derive assets from it. And the final stage of development of this program involved designing user modules that would make predictive analytic insights and offer these insights to add value in business decisions.

...

Novartis hopes to develop Nerve Live to offer features to help manage resources, including using predictive models to plan medical supplies for medical centers.

data42 Program

The data42 program is a digital research and development platform Novartis believes will help in drug discovery and drug testing while costing less. The program would include large pools of patient and pharmaceutical data and an artificial intelligence to assist researchers in their development. As of March 2020, the program was still in the initial phases of development.

Research

Gleevec

Novartis, previously called Ciba-Geigy, was one of the few pharmaceutical companies involved in tyrosine kinase inhibitor research when it began a collaboration with oncologist Brian Druker which resulted in discovery of the kinase inhibitor drug Gleevec (also known as Glivec or imatinib). Gleevec was FDA approved in 2001 to treat patients with chronic myelogenous leukemia (CML). Kinases perform phosphorylation, a mechanism that controls the activity of proteins in the cell. CML patients have a mutation causing their tyrosine kinase to be overactive, which signals cell to proliferate at a high rate, resulting in accumulation of immature white blood cells. Based on revenue, Gleevec was one of Novartis’s top ten pharmaceutical products in 2017.

Kisqali

...

Further reading  (+2 rows) (+10 cells) (+363 characters)

Title
Author
Link
Type
Date

Drug development gets big data analytics boost

Goran Mijuk

Web

July 2, 2018

The data42 program shows Novartis' intent to go big on data and digital

Goran Mijuk

Web

March 11, 2020

Infobox
Acquisitions
The Medicines Company acquired by Novartis
Legal name
Novartis International AG
Email address
eric.althoff@novartis.com
Number of Employees (ranges)
100,000+
Phone number
+41 61 324 11 11
Stock symbol
NVS
Page 1 of 2
Tikhon BernstamTikhon Bernstam was edited byErin ScherfnerErin Scherfner
September 29, 2020 8:00 pm
Topic thumbnail

Tikhon Bernstam

American businessman

American businessman and co-founder of Scribd.

Article  (+827 characters)

Tikhon Bernstam is an American businessman, founder, and angel investor, living in the San Francisco Bay area. He attended Dartmouth College, and participated in Y Combinator's accelerator program twice, once in 2006 and again in 2011.

After completing the Y Combinator program in 2006, Bernstam founded Scribd, an online reading subscription service, where users may read or listen to books, magazines, podcasts, sheet music, and other published materials. Scribd has over 80 million active users.

...

In 2011, Bernstam again attended a Y Combinator program and co-founded Parse with Kevin Lacker, James Yu, and Ilya Sukhar; as a part of the Y Combinator S11 Batch. Parse is a cloud-based software developer providing kits for building desktop, mobile, and embedded device applications. In 2013 Facebook acquired Parse for $85M.

Dr. Chris BrummerDr. Chris Brummer was edited byChris BrummerChris Brummer
September 29, 2020 7:37 pm
Further reading  (+8 rows) (+29 cells) (+882 characters)

Title
Author
Link
Type
Date

Chris Brummer - Creator of Fintech Week

Carlyn Runnels

Interview

September 17, 2020

CHRIS BRUMMER - DC Fintech Week

Web

Chris Brummer - Georgetown Law

Web

Chris Brummer - Georgetown law professor, finance and trade scholar, commentator - Professor Chris Brummer's academic papers and contribution to financial reform

Web

Chris Brummer - Medium

Web

Fintech Beat on Apple Podcasts

CQ Roll Call

Web

September 28, 2020

Fintech Beat Podcast

Web

September 29, 2020

Professor Chris Brummer - finance, trade and regulatory analysis blog - Georgetown law professor, finance and trade scholar, commentator

Web

Golden logo